ArticleBMJ open2025

Evidence quality and uncertainties considered in appraisal documents of drugs for rare diseases in England and Germany: a data extraction protocol.

Lea Wiedmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.